Last $310.27 USD
Change Today +4.25 / 1.39%
Volume 522.9K
As of 4:30 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Tessier-Lavigne Ph.D.

Director and Chairman of Compensation Committee, Agios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 81 board members in 7 different organizations across 6 different industries.

See Board Relationships
54$177,447

Background*

Dr. Marc Tessier-Lavigne, Ph.D. has been the President of The Rockefeller University since 2011, where Dr. Tessier-Lavigne also serves as a professor and head of the laboratory of brain development and repair. He is a Co-founder of Renovis Inc. He joined The Rockefeller University in 2011. He served as the Chief Scientific Officer and Executive Vice President of Research of Genentech, Inc. He served as an Executive Vice President of Research Drug Discovery of Genentech ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*

Director
Director
2011-Present
Director, Chairman of Compensation Committee and Member of Technology Committee
2011-Present
Independent Director, Member of Regulatory & Compliance Committee, Member of Regulatory & Compliance Committee and Member of Science & Technology Committee
2011-Present
Director and Chairman of Compensation Committee
2014-Present
Director

Education*

Bachelor's Degree
McGill University
Bachelor's Degree
University of Oxford
Doctorate 1987
University College London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$34,000
Total Calculated Compensation$177,447
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $310.27 USD +4.25

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.